Gail K. Boudreaux
Also at Elevance Health Inc
About
Gail K. Boudreaux is a seasoned leader in the healthcare industry with extensive personal and professional achievements. At 64 years of age , her impressive career spans decades of progressively responsible roles in major healthcare companies, which has shaped her reputation as a strategic and innovative executive.
Since joining Elevance Health in November 2017 , she has served as the President and Chief Executive Officer, spearheading initiatives that leverage her expertise in healthcare delivery, technology, and regulatory strategy. Her leadership at ELV marks a significant chapter in her career, reflecting a commitment to organizational transformation and sustainable growth.
Beyond her executive responsibilities at ELV, Gail has held various leadership positions across the healthcare sector, including roles at UnitedHealth Group, Health Care Service Corporation, and Aetna. Her board memberships and public service on organizations such as Target Corporation further support her strong influence in the industry.
$ELV Performance Under Gail K. Boudreaux
Past Roles
External Roles
Fixed Compensation
Performance Compensation
Performance Compensation Overview
Performance Stock Units (PSUs)
- Grant Date: March 1, 2023.
- Grant Date Fair Value: $7,899,872 at target performance.
- Grant Date Stock Price: $469.03 per share.
- Vesting Schedule: All PSUs vest on March 1, 2026 after completion of the 2023-2025 performance period.
- Additional Details: Dividend equivalents accrue during the vesting period and are paid if the PSUs vest.
Annual Incentive Plan (AIP)
- Target Award: $3,200,000.
- Payout Range: From 30% to 200% based on performance with an overall modifier of 80% to 120%.
- Performance Metrics and Weightings:
- Adjusted Net Income: 50%
- Operating Revenue: 20%
- Improving the Health of Humanity: 10%
- Star Ratings: 10%
- Consumer Effort: 10%
- Threshold / Targets:
- Threshold: $960,000
- Target: $3,200,000
- Maximum: $6,400,000
- Evaluation Period: 2023 (annual performance evaluation)
- Actual Results: Final Award was $3,648,000, representing 114% of the target.
- Vesting: Not applicable as this is a cash incentive plan.
This overview summarizes the performance-based components for 2023 including detailed performance metrics, payout ranges, vesting schedule for PSUs, and overall AIP targets with their respective weightings and evaluation criteria.